Finn Skou Pedersen

Corporate Officer/Principal at University of Aarhus

Health Technology

Consumer Services

Profile

Finn Skou Pedersen was the founder of EnFutech ApS, founded in 2007, where he held the title of Director.
He is also the founder of iSD Immunotech ApS, founded in 2007, where he held the title of Director from 2007 to 2018.
Currently, Mr. Pedersen is a Professor at the University of Aarhus.

Finn Skou Pedersen active positions

Companies	Position	Start
University of Aarhus	Corporate Officer/Principal	-

All active positions of Finn Skou Pedersen

Former positions of Finn Skou Pedersen

Companies	Position	End
iSD Immunotech ApS iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark.	Founder	03/12/2018
EnFutech ApS EnFutech ApS BiotechnologyHealth Technology EnFutech ApS is a holding company that develops technologies for prevention, treatment, and eradication of Human Immunodeficiency Virus (HIV). Its platforms include both a new type of inhibitor that can be used as a prophylactic agent as well as a traditional drug for treatment of infection and a gene therapeutical approach to rendering the T-cells immune to HIV infection. The firm aims to combat infection, by developing effective anti-HIV treatments that can remove the virus both before and after it infects human cells. Its treatment is based on its novel technologies of blocking the HIV co-receptors using retargeted envelope proteins and receptor interference. The company was founded by Finn Skou Pedersen and Martin Tolstrup on August 23, 2007 and is headquartered in Aarhus, Denmark.	Founder	-

See the detail of Finn Skou Pedersen's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Finn Skou Pedersen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
EnFutech ApS EnFutech ApS BiotechnologyHealth Technology EnFutech ApS is a holding company that develops technologies for prevention, treatment, and eradication of Human Immunodeficiency Virus (HIV). Its platforms include both a new type of inhibitor that can be used as a prophylactic agent as well as a traditional drug for treatment of infection and a gene therapeutical approach to rendering the T-cells immune to HIV infection. The firm aims to combat infection, by developing effective anti-HIV treatments that can remove the virus both before and after it infects human cells. Its treatment is based on its novel technologies of blocking the HIV co-receptors using retargeted envelope proteins and receptor interference. The company was founded by Finn Skou Pedersen and Martin Tolstrup on August 23, 2007 and is headquartered in Aarhus, Denmark.	Health Technology
iSD Immunotech ApS iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark.	Health Technology